Nitric oxide decreases microvascular permeability in bradykinin stimulated and nonstimulated conditions

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 6, 1999, Pages 938-947

  Arnhold, Stefan ^a   Antoine, Dirk ^a   Bläser, Harald ^a   Bloch, Wilhelm ^a   Andressen, Christian ^a   Addicks, Klaus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bradykinin; Microvascular permeability; Nitric oxide; Rat mesentery

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BRADYKININ; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM INJURY; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; BRADYKININ; CAPILLARY PERMEABILITY; DRUG INTERACTIONS; IMMUNOHISTOCHEMISTRY; MALE; MESENTERY; MICROSCOPY, ELECTRON; NADPH DEHYDROGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, WISTAR;

EID: 0032977061     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199906000-00015     Document Type: Article

References (37)

1. Ialenti A, Ignaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992; 211:177-82.
2. Mayhan WG. Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5′-diphosphate and bradykinin. Inflammation 1992;16:295-305.
3. Oliver JA. Endothelium derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 1992;151: 506-11.
4. Filep JG, Foldes-Filep E. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat. Br J Pharmacol 1993;110:1347-52.
5. Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW. cGMP and nitric oxide modulate thrombin-induced endothelial permeability: regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res 1995;76:199-208.
6. Kubes P. Nitric oxide affects microvascular permeability in the intact and inflamed vasculature. Microcirculation 1995;2:235-44.
7. Feletou M, Bonnardel E, Canet E. Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role for nitric oxide. Br J Pharmacol 1996;118:1371-6.
8. Mayhan WG. L-Arginine does not reverse impaired agonist-induced increases in macromolecular efflux during diabetes mellitus. Cardiovasc Res 1997;34:215-22.
9. Majno G, Shea M, Leventhal M. Endothelial contraction induced by histamine-type mediators: an electron microscopic study. J Cell Biol 1969;42:647-52.
10. Regoli D, Barabe JJ. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
11. Morel NMC, Dodge AB, Patton WF, Hermann LM, Hechtman HB, Shepro D. Pulmonary microvascular endothelial cell contractility on silicone rubber substrate. J Cell Physiol 1989;141:653-9.
12. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
13. Schlemper V, Calixto JB. Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea. Br J Pharmacol 1994;111:83-8.
14. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983;52:352-7.
15. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991;83:2048-56.
16. Bloch W, Hoever D, Reitze D, Kopalek L, Addicks K. Exogenously supplied nitric oxide influences the dilation of the capillary microvasculature in vivo. Agents Actions 1995;45(suppl I):151-6.
17. Förstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991;88:1788-92.
18. Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 1993; 265:G189-95.
19. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Biol 1993;9:371-7.
20. Addicks K, Bloch W, Feelisch M. Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microsc Res 1994;29:161-8.
21. Bekker AY, Ritter B, Duran WN. Analysis of microvascular permeability by video-imaging digital processing. Microvasc Res 1989;38:200-16.
22. Feelisch M, Noack EA. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol 1987;142:465-9.
23. Beesley JE. Histochemical methods for detecting nitric oxide synthase. Histochem J 1995;27:757-69.
24. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;65-70.
25. Addicks K, Bloch W, Feelisch M. Selective endothelial and neuronal localisations of NO-synthase in the heart, In: Honcada S, Stamler J, Gross S, Higgs EA, eds. Biology of nitric oxide, Part 3. London: Portland Press, 1995:434-8.
26. Khairallah PA, Page IH. Kinins and blood pressure. Lancet 1978; 2:663-5.
27. Westendorp RGJ, Draijer E, Meinders E, van Hinsbergh VWM. Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial monolayers. J Vasc Res 1994; 31:42-51.
28. Ramirez MM, Kim DD, Duran WN. Protein kinase C modulates microvascular permeability through nitric oxide. Am J Physiol 1996;271:H1702-5.
29. i and microvessel permeability. Am J Physiol 1997;272:H176-85.
30. Ross D, Joyner WL. Resting distribution and stimulated translocation of protein kinase C isoforms alpha, epsilon and zeta in response to bradykinin and TNF in human endothelial cells. Endothelium 1997;5:321-32.
31. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol 1990;258:C399-404.
32. Greiff L, Andersson M, Svensson C, et al. Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways. Allergy 1995;50:593-7.
33. Di Corleto PE, Gimbrone MA. Vascular endothelium; In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and coronary artery disease. Vol I. Philadelphia: Lippincott-Raven, 1996:387-99.
34. Gaboury JP, Niu XF, Kubes P. Nitric oxide inhibits numerous features of mast-cell induced inflammation. Circulation 1996;93: 318-26.
35. Luscher TF. Endogenous and exogenous nitrates and their role in myocardial ischaemia. Br J Pharmacol 1992;34(suppl 1):29-35.
36. Angaard EE. Endogenous and exogenous nitrates. Acta Anaesthesiol Scand Suppl 1992;97:7-10.
37. Willerson JT. Conversion from chronic to acute coronary heart disease syndromes: role of platelet products. Tex Heart Inst J 1995; 22:13-9.